CoChat

Circulating and gut-resident human Th17 cells express CD161 and promote intestinal inflammation

Open access
Kleinschek, Melanie A., Boniface, Katia, Sadekova, Svetlana, Grein, Jeff, Murphy, Erin E., Turner, Scott P., Raskin, Lisa, Desai, Bela, Faubion, William A., de Waal Malefyt, Rene, Pierce, Robert H., McClanahan, Terrill, Kastelein, Robert A. · 2009 · Journal of Experimental Medicine

The DOI matches its Crossref record; 32 of the 32 references it cites were found in a registry or an index.

Abstract

The C-type lectin-like receptor CD161, which has recently been described to promote T cell expansion, is expressed on a discrete subset of human CD4 T cells. The function of such cells, however, has remained elusive. We now demonstrate that CD161(+) CD4 T cells comprise a circulating and gut-resident T helper 17 (Th17) cell population. During Crohn's disease (CD), these CD161(+) cells display an activated Th17 phenotype, as indicated by increased expression of interleukin (IL)-17, IL-22, and IL-23 receptor. CD161(+) CD4 T cells from CD patients readily produce IL-17 and interferon gamma upon stimulation with IL-23, whereas, in healthy subjects, priming by additional inflammatory stimuli such as IL-1beta was required to enable IL-23-induced cytokine release. Circulating CD161(+) Th17 cells are imprinted for gut homing, as indicated by high levels of CC chemokine receptor 6 and integrin beta7 expression. Supporting their colitogenic phenotype, CD161(+) Th17 cells were found in increased numbers in the inflammatory infiltrate of CD lesions and induced expression of inflammatory mediators by intestinal cells. Our data identify CD161(+) CD4 T cells as a resting Th17 pool that can be activated by IL-23 and mediate destructive tissue inflammation.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1084/jem.20081712

Cites

32 of 32 references verified0 citation errors · 0 not checkable

Statistics

Figures

Figure 1. CD161 expression identifies tissue-resident and circulating Th17 cells. (A–D) LPMCs were isolated from non-CD colon specimens. (A) Flow cytometric analysis for IL-23R expression gated on CD45RO+CD4+ T cells. The plot is representative of five independent donors. (B–D) CD4+CD45RO+ T memory cells were FACS sorted for CD161 expression. il23r (B; data are from three individual donors) or il17, il22, and ifng (C; data are representative of two donors) expression was assessed by qRT-PCR and normalized to ubiquitin. Cells were cultured for 3 d with anti-CD2/anti-CD3/anti-CD28 activation beads for measurement of IL-17 production (D; data are from two different donors). The dashed line indicates the lower limit of detection. (E and F) PBMCs from healthy donors were FACS sorted for CD161+ and CD161− CD4+CD25−CD45RA− T memory cells, and gene expression was profiled (E; data are from four different donors; the dashed line indicates twofold change). The boxes indicate interquartile range with median, and whiskers define minimum to maximum values. Cytokine production was determined after 3 d of culture with anti-CD2/anti-CD3/anti-CD28 activation beads. (F; data are representative of at least three donors from independent experiments).
Figure 1. CD161 expression identifies tissue-resident and circulating Th17 cells. (A–D) LPMCs were isolated from non-CD colon specimens. (A) Flow cytometric analysis for IL-23R expression gated on CD45RO+CD4+ T cells. The plot is representative of five independent donors. (B–D) CD4+CD45RO+ T memory cells were FACS sorted for CD161 expression. il23r (B; data are from three individual donors) or il17, il22, and ifng (C; data are representative of two donors) expression was assessed by qRT-PCR and normalized to ubiquitin. Cells were cultured for 3 d with anti-CD2/anti-CD3/anti-CD28 activation beads for measurement of IL-17 production (D; data are from two different donors). The dashed line indicates the lower limit of detection. (E and F) PBMCs from healthy donors were FACS sorted for CD161+ and CD161− CD4+CD25−CD45RA− T memory cells, and gene expression was profiled (E; data are from four different donors; the dashed line indicates twofold change). The boxes indicate interquartile range with median, and whiskers define minimum to maximum values. Cytokine production was determined after 3 d of culture with anti-CD2/anti-CD3/anti-CD28 activation beads. (F; data are representative of at least three donors from independent experiments).CC BY-NC-SA · PubMed Central
Figure 2. Activated Th17 phenotype in CD161+ CD4 T memory from CD patients. PBMCs from healthy donors and CD patients were isolated. (A and B) CD4+CD25−CD45RA− T memory cells were FACS purified and cultured with PMA and ionomycin for 4.5 h, and were then stained for CD161 and IL-17 (A) or IFN-γ (B). FACS plots show cytokine production in relation to CD161 expression from one representative CD case. Box plots present cytokine-positive cells as a percentage of CD161+ or CD161− CD4 T memory cells. Boxes show the interquartile range (the whiskers show minimum to maximum; data are from eight different donors). (C) Flow cytometric analysis of CD161+ CD4+CD45RO+ T cells for IL-23R expression. The box plot shows the frequency of IL-23R+ cells determined as the mean value of two separate stains per donor. The boxes show data from 25 different donors as an interquartile range, with whiskers from the 10th to the 90th percentile (outliers are displayed as dots). (D) CD161+ CD4+CD45RA−CD25− T memory cells from healthy and CD donors were cultured for 3 d with anti-CD2/anti-CD3/anti-CD28 beads with or without IL-23. Supernatant was assessed for IL-17, IL-22, and IFN-γ. Data are from nine different donors, and lines connect data points representing the same donor. (E) IL-23–induced x-fold increase in cytokine production by CD161+ CD4+CD45RA−CD25− T memory cells from healthy and CD donors calculated from the data depicted in D. The dashed line indicates baseline at onefold change.
Figure 2. Activated Th17 phenotype in CD161+ CD4 T memory from CD patients. PBMCs from healthy donors and CD patients were isolated. (A and B) CD4+CD25−CD45RA− T memory cells were FACS purified and cultured with PMA and ionomycin for 4.5 h, and were then stained for CD161 and IL-17 (A) or IFN-γ (B). FACS plots show cytokine production in relation to CD161 expression from one representative CD case. Box plots present cytokine-positive cells as a percentage of CD161+ or CD161− CD4 T memory cells. Boxes show the interquartile range (the whiskers show minimum to maximum; data are from eight different donors). (C) Flow cytometric analysis of CD161+ CD4+CD45RO+ T cells for IL-23R expression. The box plot shows the frequency of IL-23R+ cells determined as the mean value of two separate stains per donor. The boxes show data from 25 different donors as an interquartile range, with whiskers from the 10th to the 90th percentile (outliers are displayed as dots). (D) CD161+ CD4+CD45RA−CD25− T memory cells from healthy and CD donors were cultured for 3 d with anti-CD2/anti-CD3/anti-CD28 beads with or without IL-23. Supernatant was assessed for IL-17, IL-22, and IFN-γ. Data are from nine different donors, and lines connect data points representing the same donor. (E) IL-23–induced x-fold increase in cytokine production by CD161+ CD4+CD45RA−CD25− T memory cells from healthy and CD donors calculated from the data depicted in D. The dashed line indicates baseline at onefold change.CC BY-NC-SA · PubMed Central
Figure 3. IL-23 drives IL-17 and IFN-γ production by CD161+ Th17 cells during inflammation. CD161+ and CD161− CD45RA−CD25−CD4+ T memory cells were FACS purified from PBMCs from healthy and CD donors. (A) Expression levels of il1r1 were determined by qRT-PCR and normalized to ubiquitin; data are from five different donors. Connecting lines indicate data points referring to the same donor. (B–F) Cells from healthy (B–E) or CD (F) donors were cultured for 3 d with anti-CD2/anti-CD3/anti-CD28 beads only or with the addition of IL-23 and/or IL-1β as indicated. (B) Protein levels for IL-17, IL-22, and IFN-γ in culture supernatant from normal CD4 T memory cells. Data shown from 8 donors are representative of 15 donors from independent experiments. (C and D) Frequency of viable cells was measured in a colorimetric assay based on enzymatic activity. Cell viability after culture without cytokine stimulation (C) was set as the 100% value to calculate cytokine-induced proliferative responses per donor (D). The bar diagram represents mean values for the eight different donors depicted in C (error bars = SD). The dashed line indicates baseline proliferation in cultures without cytokine stimulation set as 100% value. (E) Transcriptional expression of il17, il22, and ifng in T cells from healthy donors was assessed by qRT-PCR. CD161+ cells from 11 different donors were analyzed with corresponding analysis for CD161− cells from 4 of those donors. (F) IL-17, IL-22, and IFN-γ protein levels in culture supernatant from CD patients' T cells. Data are shown for eight different donors. IL-17 levels for CD subject no. 8 exceeded the scale (values for CD161+ cells with values for CD161− cells in brackets: media, 4,298 [497] pg/ml; IL-23, 7,198 [1,248] pg/ml; IL-1β, 7,943 [946] pg/ml; and IL-23 + IL-1β, 10,911 [1,386] pg/ml). Individual symbols represent individual donors to visualize trends per donor (B, E, and F). Horizontal bars represent medians (B, C, E, and F).
Figure 3. IL-23 drives IL-17 and IFN-γ production by CD161+ Th17 cells during inflammation. CD161+ and CD161− CD45RA−CD25−CD4+ T memory cells were FACS purified from PBMCs from healthy and CD donors. (A) Expression levels of il1r1 were determined by qRT-PCR and normalized to ubiquitin; data are from five different donors. Connecting lines indicate data points referring to the same donor. (B–F) Cells from healthy (B–E) or CD (F) donors were cultured for 3 d with anti-CD2/anti-CD3/anti-CD28 beads only or with the addition of IL-23 and/or IL-1β as indicated. (B) Protein levels for IL-17, IL-22, and IFN-γ in culture supernatant from normal CD4 T memory cells. Data shown from 8 donors are representative of 15 donors from independent experiments. (C and D) Frequency of viable cells was measured in a colorimetric assay based on enzymatic activity. Cell viability after culture without cytokine stimulation (C) was set as the 100% value to calculate cytokine-induced proliferative responses per donor (D). The bar diagram represents mean values for the eight different donors depicted in C (error bars = SD). The dashed line indicates baseline proliferation in cultures without cytokine stimulation set as 100% value. (E) Transcriptional expression of il17, il22, and ifng in T cells from healthy donors was assessed by qRT-PCR. CD161+ cells from 11 different donors were analyzed with corresponding analysis for CD161− cells from 4 of those donors. (F) IL-17, IL-22, and IFN-γ protein levels in culture supernatant from CD patients' T cells. Data are shown for eight different donors. IL-17 levels for CD subject no. 8 exceeded the scale (values for CD161+ cells with values for CD161− cells in brackets: media, 4,298 [497] pg/ml; IL-23, 7,198 [1,248] pg/ml; IL-1β, 7,943 [946] pg/ml; and IL-23 + IL-1β, 10,911 [1,386] pg/ml). Individual symbols represent individual donors to visualize trends per donor (B, E, and F). Horizontal bars represent medians (B, C, E, and F).CC BY-NC-SA · PubMed Central
Figure 4. CD161+ Th17 cells are imprinted for gut homing and contribute to the inflammatory infiltrate in CD. (A–E) PBMCs from healthy donors and CD patients were isolated and analyzed by flow cytometry. The proportion of CCR6+ cells of normal (A and B) and CD (B) CD161+ and CD161− CD4+CD45RO+ T memory cells. Stains were performed in duplicates, and the mean value per donor from 14 different healthy and CD donors is shown. (C) Distribution of integrin β7+ cells gated on total normal CD4+CD45RA− T memory cells (left), and distribution of integrin α4+ cells gated on total normal integrin β7+ CD4+CD45RA− T memory cells (right; data are representative of eight different donors). (D and E) Frequency (D) or mean fluorescence intensity (MFI; E) of integrin β7+ cells of either CD161+ or CD161− CD4+CD45RA− T memory cells from healthy donors and CD patients; data are from 12 different healthy and 14 different CD donors. (F–H) LPMCs were isolated from CD and control patients' colon resections. The total number per full thickness tissue weight (F) and frequency (G) of CD161+ CD4 T cells were determined by flow cytometry. n.a., no tissue weight available. (H) flow cytometric analysis of LPMCs for CCR6 and β7-integrin expression gated on CD161+ CD4+CD45RA− T memory cells. Plots show data from three different experiments with two different control and two different CD cases, and nonlesional tissue available from one CD patient. Horizontal bars represent medians (B and D–G).
Figure 4. CD161+ Th17 cells are imprinted for gut homing and contribute to the inflammatory infiltrate in CD. (A–E) PBMCs from healthy donors and CD patients were isolated and analyzed by flow cytometry. The proportion of CCR6+ cells of normal (A and B) and CD (B) CD161+ and CD161− CD4+CD45RO+ T memory cells. Stains were performed in duplicates, and the mean value per donor from 14 different healthy and CD donors is shown. (C) Distribution of integrin β7+ cells gated on total normal CD4+CD45RA− T memory cells (left), and distribution of integrin α4+ cells gated on total normal integrin β7+ CD4+CD45RA− T memory cells (right; data are representative of eight different donors). (D and E) Frequency (D) or mean fluorescence intensity (MFI; E) of integrin β7+ cells of either CD161+ or CD161− CD4+CD45RA− T memory cells from healthy donors and CD patients; data are from 12 different healthy and 14 different CD donors. (F–H) LPMCs were isolated from CD and control patients' colon resections. The total number per full thickness tissue weight (F) and frequency (G) of CD161+ CD4 T cells were determined by flow cytometry. n.a., no tissue weight available. (H) flow cytometric analysis of LPMCs for CCR6 and β7-integrin expression gated on CD161+ CD4+CD45RA− T memory cells. Plots show data from three different experiments with two different control and two different CD cases, and nonlesional tissue available from one CD patient. Horizontal bars represent medians (B and D–G).CC BY-NC-SA · PubMed Central
Figure 5. Activated CD161+ Th17 cells promote intestinal inflammation. CD161+ and CD161− CD4+CD45RA−CD25− T memory cells were purified from normal PBMCs. Cells were cultured for 3 d in the presence of anti-CD2/anti-CD3/anti-CD28 activation beads with or without IL-23 and IL-1β. Cell-free supernatant was used to stimulate HT-29 colonic epithelial cells (A and B) or 18Co colonic myofibroblasts (C). (A) Chemokines in HT-29 supernatant were measure by ELISA. Data for three T cell donors are shown as representative of eight different donors. (B) Supernatant from IL-23/IL-1β–activated T cells was used to stimulate HT-29 cells. Where indicated, the supernatant was pretreated with monoclonal anti–IL-17 and/or IL-22BP to neutralize the respective cytokine. Chemokine levels after stimulation with untreated supernatant from CD161+ CD4 T memory cells were set as the100% value for each donor (dashed line), and expression for all other stimulations is shown as the percentage thereof. Individual symbols refer to individual donors. Data show five T cell donors from three different experiments. Horizontal bars represent medians. (C) Transcriptional expression of CCL20, IL-6, and TNF in stimulated 18Co cells was measured by qRT-PCR and is depicted as the mean and SD for two different T cell donors.
Figure 5. Activated CD161+ Th17 cells promote intestinal inflammation. CD161+ and CD161− CD4+CD45RA−CD25− T memory cells were purified from normal PBMCs. Cells were cultured for 3 d in the presence of anti-CD2/anti-CD3/anti-CD28 activation beads with or without IL-23 and IL-1β. Cell-free supernatant was used to stimulate HT-29 colonic epithelial cells (A and B) or 18Co colonic myofibroblasts (C). (A) Chemokines in HT-29 supernatant were measure by ELISA. Data for three T cell donors are shown as representative of eight different donors. (B) Supernatant from IL-23/IL-1β–activated T cells was used to stimulate HT-29 cells. Where indicated, the supernatant was pretreated with monoclonal anti–IL-17 and/or IL-22BP to neutralize the respective cytokine. Chemokine levels after stimulation with untreated supernatant from CD161+ CD4 T memory cells were set as the100% value for each donor (dashed line), and expression for all other stimulations is shown as the percentage thereof. Individual symbols refer to individual donors. Data show five T cell donors from three different experiments. Horizontal bars represent medians. (C) Transcriptional expression of CCL20, IL-6, and TNF in stimulated 18Co cells was measured by qRT-PCR and is depicted as the mean and SD for two different T cell donors.CC BY-NC-SA · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Research works printed but not linked: 1

  1. Warrington, 2001, CD4+,CD28− T cells in rheumatoid arthritis patients combine features of the innate and adaptive immune systems, Arthritis Rheum., 44, 13, 10.1002/1529-0131(200101)44:1<13::AID-ANR3>3.0.CO;2-6 · doi:10.1002/1529-0131(200101)44:1<13::aid-anr3>3.0.co;2-6

Cited by

See all 460

Metadata

Authors
Kleinschek, M. A., Boniface, K., Sadekova, S., Grein, J., Murphy, E. E., Turner, S. P., Raskin, L., Desai, B., Faubion, W. A., de Waal Malefyt, R., Pierce, R. H., McClanahan, T., & Kastelein, R. A.
Affiliations
  • Department of Immunology 1 and 2
  • Mayo Clinic (US)
Corresponding author
Kleinschek, Melanie A.
Venue
Journal of Experimental Medicine
Published
2009-03-09
Volume
206
Issue
3
Pages
525-534
ISSN
  • 0022-1007 (ISSN-L)
  • 1540-9538
OpenAlex
W1975164490
Cited by
460
References
32
Citations by year
2026: 6 · 2025: 8 · 2024: 12 · 2023: 16 · 2022: 15 · 2021: 18 · 2020: 20 · 2019: 22 · 2018: 20 · 2017: 31 · 2016: 35 · 2015: 29 · 2014: 34 · 2013: 36 · 2012: 38
FWCI
22.43
Type
journal article
Language
en
Open access
Locations
  • The Journal of Experimental Medicine (publishedVersion)
  • PubMed Central (publishedVersion, cc-by-nc-sa)
  • PubMed (publishedVersion)
Topics
  • Life Sciences › Immunology and Microbiology › Immunology › Psoriasis: Treatment and Pathogenesis
  • Health Sciences › Medicine › Gastroenterology › Inflammatory Bowel Disease
  • Life Sciences › Immunology and Microbiology › Immunology › T-cell and B-cell Immunology
Keywords
CD161, Th17 cells, CD4+ T cells, Crohn's disease, intestinal inflammation, IL-23, IL-17, IL-22, IL23R, gut homing, CCR6, beta7 integrin, T cell activation, colitis
MeSH terms
Cell Movement, Crohn Disease, T-Lymphocytes, Helper-Inducer, Humans, Immunologic Memory, Inflammation, Interferon-gamma, Intestines, Lymphocyte Activation, Organ Specificity, Phenotype, Interleukin-17, Interleukin-23, NK Cell Lectin-Like Receptor Subfamily B

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.